Detalhe da pesquisa
1.
Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era - real-world data from Hungary.
Ann Hematol
; 102(9): 2555-2563, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428200